Hologic Inc
NASDAQ:HOLX
Intrinsic Value
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. [ Read More ]
The intrinsic value of one HOLX stock under the Base Case scenario is 64.48 USD. Compared to the current market price of 77.35 USD, Hologic Inc is Overvalued by 17%.
Valuation Backtest
Hologic Inc
Run backtest to discover the historical profit from buying and selling HOLX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Hologic Inc's business.
What risks and challenges
does Hologic Inc face in the near future?
Summarize the latest earnings report
of Hologic Inc.
Provide P/E
for Hologic Inc and its competitors.
Balance Sheet Decomposition
Hologic Inc
Current Assets | 3.5B |
Cash & Short-Term Investments | 1.9B |
Receivables | 670.9m |
Other Current Assets | 891.2m |
Non-Current Assets | 5B |
PP&E | 527m |
Intangibles | 4.1B |
Other Non-Current Assets | 309.7m |
Current Liabilities | 899m |
Accounts Payable | 183.8m |
Accrued Liabilities | 484m |
Other Current Liabilities | 231.2m |
Non-Current Liabilities | 2.9B |
Long-Term Debt | 2.5B |
Other Non-Current Liabilities | 379.3m |
Earnings Waterfall
Hologic Inc
Revenue
|
4B
USD
|
Cost of Revenue
|
-1.8B
USD
|
Gross Profit
|
2.2B
USD
|
Operating Expenses
|
-1.3B
USD
|
Operating Income
|
904.3m
USD
|
Other Expenses
|
-389.2m
USD
|
Net Income
|
515.1m
USD
|
Free Cash Flow Analysis
Hologic Inc
What is Free Cash Flow?
HOLX Profitability Score
Profitability Due Diligence
Hologic Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Hologic Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
HOLX Solvency Score
Solvency Due Diligence
Hologic Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Hologic Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HOLX Price Targets Summary
Hologic Inc
According to Wall Street analysts, the average 1-year price target for HOLX is 86.19 USD with a low forecast of 76.76 USD and a high forecast of 99.75 USD.
Ownership
HOLX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
HOLX Price
Hologic Inc
Average Annual Return | 13.33% |
Standard Deviation of Annual Returns | 18.5% |
Max Drawdown | -46% |
Market Capitalization | 18.1B USD |
Shares Outstanding | 234 732 000 |
Percentage of Shares Shorted | 3.49% |
HOLX News
Last Important Events
Hologic Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Hologic Inc
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts and currently employs 6,705 full-time employees. The firm operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.
Contact
IPO
Employees
Officers
The intrinsic value of one HOLX stock under the Base Case scenario is 64.48 USD.
Compared to the current market price of 77.35 USD, Hologic Inc is Overvalued by 17%.